315 related articles for article (PubMed ID: 15312243)
1. Intracellular machinery for matrix degradation in bone-resorbing osteoclasts.
Vääräniemi J; Halleen JM; Kaarlonen K; Ylipahkala H; Alatalo SL; Andersson G; Kaija H; Vihko P; Väänänen HK
J Bone Miner Res; 2004 Sep; 19(9):1432-40. PubMed ID: 15312243
[TBL] [Abstract][Full Text] [Related]
2. Potential function for the ROS-generating activity of TRACP.
Halleen JM; Räisänen SR; Alatalo SL; Väänänen HK
J Bone Miner Res; 2003 Oct; 18(10):1908-11. PubMed ID: 14584905
[TBL] [Abstract][Full Text] [Related]
3. Cystatin B as an intracellular modulator of bone resorption.
Laitala-Leinonen T; Rinne R; Saukko P; Väänänen HK; Rinne A
Matrix Biol; 2006 Apr; 25(3):149-57. PubMed ID: 16321512
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice.
Zenger S; Hollberg K; Ljusberg J; Norgård M; Ek-Rylander B; Kiviranta R; Andersson G
Bone; 2007 Nov; 41(5):820-32. PubMed ID: 17765026
[TBL] [Abstract][Full Text] [Related]
6. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.
Henriksen K; Sørensen MG; Nielsen RH; Gram J; Schaller S; Dziegiel MH; Everts V; Bollerslev J; Karsdal MA
J Bone Miner Res; 2006 Jan; 21(1):58-66. PubMed ID: 16355274
[TBL] [Abstract][Full Text] [Related]
7. Endogenous expression and endocytosis of tartrate-resistant acid phosphatase (TRACP) by osteoblast-like cells.
Perez-Amodio S; Vogels IM; Schoenmaker T; Jansen DC; Alatalo SL; Halleen JM; Beertsen W; Everts V
Bone; 2005 Jun; 36(6):1065-77. PubMed ID: 15878315
[TBL] [Abstract][Full Text] [Related]
8. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
[TBL] [Abstract][Full Text] [Related]
9. The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking.
Leung P; Pickarski M; Zhuo Y; Masarachia PJ; Duong LT
Bone; 2011 Oct; 49(4):623-35. PubMed ID: 21718816
[TBL] [Abstract][Full Text] [Related]
10. Macrophages overexpressing tartrate-resistant acid phosphatase show altered profile of free radical production and enhanced capacity of bacterial killing.
Räisänen SR; Alatalo SL; Ylipahkala H; Halleen JM; Cassady AI; Hume DA; Väänänen HK
Biochem Biophys Res Commun; 2005 May; 331(1):120-6. PubMed ID: 15845367
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation.
Koh JM; Lee YS; Kim YS; Kim DJ; Kim HH; Park JY; Lee KU; Kim GS
J Bone Miner Res; 2006 Jul; 21(7):1003-11. PubMed ID: 16813521
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts.
Fuller K; Lawrence KM; Ross JL; Grabowska UB; Shiroo M; Samuelsson B; Chambers TJ
Bone; 2008 Jan; 42(1):200-11. PubMed ID: 17962093
[TBL] [Abstract][Full Text] [Related]
13. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
[TBL] [Abstract][Full Text] [Related]
14. Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase.
Halleen JM; Räisänen S; Salo JJ; Reddy SV; Roodman GD; Hentunen TA; Lehenkari PP; Kaija H; Vihko P; Väänänen HK
J Biol Chem; 1999 Aug; 274(33):22907-10. PubMed ID: 10438453
[TBL] [Abstract][Full Text] [Related]
15. Calvarial osteoclasts express a higher level of tartrate-resistant acid phosphatase than long bone osteoclasts and activation does not depend on cathepsin K or L activity.
Perez-Amodio S; Jansen DC; Schoenmaker T; Vogels IM; Reinheckel T; Hayman AR; Cox TM; Saftig P; Beertsen W; Everts V
Calcif Tissue Int; 2006 Oct; 79(4):245-54. PubMed ID: 17033726
[TBL] [Abstract][Full Text] [Related]
16. Polarization and secretion of cathepsin K precede tartrate-resistant acid phosphatase secretion to the ruffled border area during the activation of matrix-resorbing clasts.
Hollberg K; Nordahl J; Hultenby K; Mengarelli-Widholm S; Andersson G; Reinholt FP
J Bone Miner Metab; 2005; 23(6):441-9. PubMed ID: 16261450
[TBL] [Abstract][Full Text] [Related]
17. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
[TBL] [Abstract][Full Text] [Related]
18. A new heterozygous mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts.
Del Fattore A; Fornari R; Van Wesenbeeck L; de Freitas F; Timmermans JP; Peruzzi B; Cappariello A; Rucci N; Spera G; Helfrich MH; Van Hul W; Migliaccio S; Teti A
J Bone Miner Res; 2008 Mar; 23(3):380-91. PubMed ID: 17997709
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts.
Ljusberg J; Wang Y; Lång P; Norgård M; Dodds R; Hultenby K; Ek-Rylander B; Andersson G
J Biol Chem; 2005 Aug; 280(31):28370-81. PubMed ID: 15929988
[TBL] [Abstract][Full Text] [Related]
20. Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation.
Nishi Y; Atley L; Eyre DE; Edelson JG; Superti-Furga A; Yasuda T; Desnick RJ; Gelb BD
J Bone Miner Res; 1999 Nov; 14(11):1902-8. PubMed ID: 10571690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
